Navigation Links
ER Wait Times Getting Longer
Date:1/15/2008

r one minute longer, for women -- Kellermann said it may be that women's heart attack symptoms still aren't recognized as quickly as men's symptoms are. "My hunch is while we're doing a better job understanding that women have heart attacks, too, a woman coming in with chest pain may be given a little less credence than a man with chest pain," he noted.

Wilper said because the causes of the increased wait time are multi-factorial, the solution has to be multi-faceted. "Solutions are likely going to be broad-based," he said.

He said there needs to be an expansion of insurance coverage, modified management of inpatient and elective surgeries because so many ER beds have been lost, and an expansion of primary care that might help ease the overflow at the emergency room.

"This is an issue that cuts across insurance status," said Kellermann, who pointed out that even people with insurance are left waiting in ERs, because there just isn't enough space or enough resources.

"Too many hospital administrators think that the hospital begins on the second floor, but ERs need open spaces and open bays. It's what we used to do, and the problem today is that more and more, we just don't have open space for a heart attack patient. We're like a NASCAR pit crew. We're designed to immediately assess, stabilize and move patients [to treatment]," said Kellermann. Without the open space, he said, the ER health-care team wastes valuable time moving patients and equipment around to try to get to the next patient.

More information

Visit the American College of Emergency Physicians to learn when an ER visit is warranted.



SOURCES: Andrew Wilper, M.D., fellow, general internal medicine, Harvard Medic
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Foundation Radiology Group Formalizes Strategic Partnership with Emageon to Provide Advanced Imaging Software to Facilitate Industry-Leading Turnaround and Patient Care Response Times
2. Most Medicare Drug Plans Continue to Hike Costs into 2008 Two-to-Three Times Rate of Inflation
3. Light powered platinum more targeted and 80 times more powerful than similar cancer treatments
4. Study: Short sleep times in patients with chronic medical diagnoses linked to obesity
5. YOU: Staying Young Fourth New York Times Best-Seller for RealAge Test Creator Dr. Michael Roizen!
6. Louisiana Tech professor is Small Times Innovator of the Year
7. Statement from American Association for Homecare on New York Times Article about Home Oxygen Therapy
8. CQRC Statement on the NY Times Article on Medicares Home Oxygen Benefit
9. People overestimate their self-reported sleep times compared to measures by a sleep test
10. Prostate cancer increases hip fracture risk by eight times in 50 to 65 year-olds
11. Rutgers College of Nursing faculty member Rachel Jones wins New York Times Nurse Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ER Wait Times Getting Longer
ER Wait Times Getting Longer
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...ntists have conducted a study, the first of its ki...he experiment was performed on mice, yet scientist.... The cause for Type 2 diabetes is still unknow... this. Yet one of the features of this disease is...
...archers at UT Southwestern Medical Center have fou...n inducing hypertension. "We have discovered that...f the risk of hypertension, it actually induces hy...asin, associate professor of internal medicine and...
...ious studies have shown that inflammation may some...alignant. UCSF scientists// have now discovered wh...cally, the "innate" immune system's Pac-Man-like w...and destroy invading microbes when receptors on th...
...archers at San Antonio's South Texas Center for Em...onio Health Science Center// (UTHSC) have come tog...hat will prevent Chlamydia. Chlamydia is a common...y the bacterium, Chlamydia trachomatis, which can ...
Other Medicine News:Health News:Cholesterol and Insulin Secretion -bound by a Gene 2Health News:C-Reactive Protein Induces Hypertension 2Health News:Inflammation can Lead to Cancer 2Health News:A Combined Research for Producing Chlamydia Vaccine Begins 2
(Date:8/19/2008)...swire-FirstCall/ -- Vical Incorporated,(Nasdaq: V...h the Karolinska,Institutet (KI), a leading Europe...or Infectious Disease Control (SMI), a governmenta...adjuvant with the Biojector(R),2000 needle-free in...,OTCBB: BJCT) for a multivalent preventive DNA vac...
(Date:8/19/2008)... /- VION,PHARMACEUTICALS, I...d,entered into an agreement with the Dutch-Belgian...the "HOVON") to conduct a clinical trial of,laromu...emission-induction,therapy in patients aged 18-65 ...ia (AML) and high-risk myelodysplasia (MDS)., Ala...
(Date:8/18/2008).../PRNewswire-USNewswire/ -- Due to an,exceptionally...s in,southeastern Pennsylvania, the Department of ...ill be stepping up efforts this week to combat the...ely to carry -- the virus., While only one human ...s year (a 27-year-old Montgomery County woman), DE...
(Date:8/18/2008)...re-USNewswire/ -- Boston University and Aubrey,Mil... Human Genetics, Inc.,("CHG") and Director of the ...nounced that CHG will no longer offer testing serv...tics, Inc., These patented tests include tests re... or Connexin 26 mutations, developmental disorders...
Breaking Medicine Technology:Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 1Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 2Saladax Biomedicals 5 FU Personalized Chemotherapy Management 28PCM 28R 29 29 Assay CE Marked for Distribution in the EU 2457 3Gene mutation improves leukemia drugs effect 22091 1Gene mutation improves leukemia drugs effect 22091 2People with lower incomes lower education levels have higher death rates 22089 1People with lower incomes lower education levels have higher death rates 22089 2Scientists discover DNA knot keeps viral genes tightly corked inside shell 3667 1Scientists discover DNA knot keeps viral genes tightly corked inside shell 3667 2
..., 2007 /PRNewswire-FirstCall/ --,SuperGen Inc. ann...ons at the American Association for Cancer Researc...ese presentations,will focus on data concerning ma...ng its lead tyrosine kinase inhibitor compound,MP...target involved,in cancer cell drug resistance. Pr...
... 2007 -- CytImmune, a,clinical stage nanomedicine...ization of multifunctional, tumor-targeted therapi...at the 43rd American,Society of Clinical Oncology ...poster session will take place from 8:00 am to 12,...mmune will,present the poster abstract entitled "P...
Other Medicine Technology:SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 2SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 3SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 4CytImmune To Present At ASCO Phase I Clinical Trial of CYT-6091 to,be Presented on June 3, 2007 2
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.
Quatroloc Revision Hip System
A stable revision design with extensive sizes
Medicine Products: